<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60530">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02317952</url>
  </required_header>
  <id_info>
    <org_study_id>PRG-VA-14-001</org_study_id>
    <nct_id>NCT02317952</nct_id>
  </id_info>
  <brief_title>Formula for Children With Cow's Milk Allergy</brief_title>
  <official_title>A Double-Blind, Randomized, Crossover Allergy Study of an Experimental Formula Followed by a 16 Week Double Blind Feeding Period to Assess Growth, Safety and Development of Tolerance to Cow's Milk Protein</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Perrigo Nutritionals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Perrigo Nutritionals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if a new extensively hydrolyzed formula can be
      consumed by children with Cow's Milk Allergy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Allergic Reaction</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Growth</measure>
    <time_frame>16 weeks</time_frame>
    <description>Anthropometric measurements of weight in all enrolled subjects.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth</measure>
    <time_frame>16 weeks</time_frame>
    <description>Anthropometric measurements of length/height in all enrolled subjects.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Milk Allergy</condition>
  <arm_group>
    <arm_group_label>New Extensively Hydrolyzed Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administered in context of oral food challenge and then for 16 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator Formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administered in context of oral food challenge and then for 16 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Extensively Hydrolyzed Formula</intervention_name>
    <arm_group_label>New Extensively Hydrolyzed Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Active Comparator Formula</intervention_name>
    <arm_group_label>Comparator Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Good health

          -  Parent/guardian must be willing to provide informed consent

          -  Parent/guardian agrees to feed study formula provided

          -  Confirmation of Cow's Milk Allergy

        Exclusion Criteria:

          -  No clinically significant abnormal findings on medical history, laboratory results,
             and physical exam.

          -  No medications that may interfere with or impact evaluation of the study assessments

          -  Allergy to extensively hydrolyzed casein formula

          -  Tolerance of 200 ml of cow's milk, cow's milk-based formula or food products
             containing intact cow's milk protein within 2 weeks of the Screening Visit

          -  Participation in another clinical trial within 30 days of screening where they are
             are receiving an active intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cindy M Barber, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Perrigo Nutritionals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cindy M Barber, PhD</last_name>
    <phone>540-832-1961</phone>
    <email>cindy.barber@perrigo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical Research Center of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Arkansas Children's Hosptial</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LeAnn Ramsey</last_name>
      <phone>501-364-2391</phone>
    </contact>
    <investigator>
      <last_name>Robert Pesek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatric Care Medical Group</name>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <zip>92647</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harmony Griner</last_name>
      <phone>714-842-1441</phone>
      <email>harmony@pediatriccare.net</email>
    </contact>
    <investigator>
      <last_name>Paul Qaqundah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Figueroa</last_name>
      <phone>323-361-4537</phone>
    </contact>
    <investigator>
      <last_name>Jonathan Tam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Choc Psf, Amc</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Allergy Medical Group of the North Area, INC</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95678</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Rondeau</last_name>
      <phone>916-782-7758</phone>
    </contact>
    <investigator>
      <last_name>Sunil Perera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allergy &amp; Asthma Medical Group and Research Center, APC</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Tate</last_name>
      <phone>858-268-2368</phone>
      <email>state@allergyandasthma.com</email>
    </contact>
    <investigator>
      <last_name>Michael Welch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>1st Allergy and Clinical Research Group, INC, d/b/a IMMUNOe International Research Centers</name>
      <address>
        <city>Centennial</city>
        <state>Colorado</state>
        <zip>80112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Sneeze Wheeze and Itch Associates</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>61761</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caitlin Demont</last_name>
      <phone>309-452-0995</phone>
      <email>caitlindemont@asthma2.com</email>
    </contact>
    <investigator>
      <last_name>Dareen Siri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute for Allergy and Asthma</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamara Johnson</last_name>
      <phone>301-986-9262</phone>
      <email>iaaresearchtamara@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Athena Economides, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Einstein Consulting Services, LLC &amp; Virgo Carter Pediatrics</name>
      <address>
        <city>Silver Spring</city>
        <state>Maryland</state>
        <zip>20910</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rick Sipe</last_name>
      <phone>301-275-5571</phone>
      <email>rick.sipe@certified-researchers.com</email>
    </contact>
    <investigator>
      <last_name>Gabrielle Virgo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Institute</name>
      <address>
        <city>Plymouth</city>
        <state>Minnesota</state>
        <zip>55441</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karla McBrady</last_name>
      <phone>763-744-1140</phone>
      <email>karla.mcbrady@criminnesota.com</email>
    </contact>
    <investigator>
      <last_name>Allan Stillerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Solutions, LLC</name>
      <address>
        <city>Middleburg Heights</city>
        <state>Ohio</state>
        <zip>44130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Allergy, Asthma, and Clinical Research Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Nassar</last_name>
      <phone>405-752-0393</phone>
    </contact>
    <investigator>
      <last_name>Martha Tarpay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolina Ear Nose and Throat Clinic</name>
      <address>
        <city>Orangeburg</city>
        <state>South Carolina</state>
        <zip>29118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miranda Brown</last_name>
      <phone>803-536-0636</phone>
    </contact>
    <investigator>
      <last_name>John Ansley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>TTS Research</name>
      <address>
        <city>Boerne</city>
        <state>Texas</state>
        <zip>78006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>STAAMP Clinical Research</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Rodriguez</last_name>
      <phone>210-451-9911</phone>
      <email>crc@staampallergy.com</email>
    </contact>
    <investigator>
      <last_name>Erika Gonzalez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 18, 2016</lastchanged_date>
  <firstreceived_date>December 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Milk Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
